Cortes J, Apperley JF, Lomaia E, Moiraghi B, et al. Ponatinib Dose-Ranging Study in Chronic-Phase Chronic Myeloid Leukemia: A Randomized, Open-Label Phase 2 Clinical Trial. Blood 2021 Aug 18. pii: 476603. doi: 10.1182/blood.2021012082.
PMID: 34407543